Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

129.89 -0.39 (-0.30%)
Official Closing Price Updated: 4:10 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
42 43 Next >
Profit from the Artificial Intelligence Boom with These 7 AI ETFs
The artificial intelligence revolution is already here, creating a massive $1.81 trillion opportunity for AI ETFs. 
Via InvestorPlace
What's In Store For Abbott Laboratories In Q1 Earnings?
Abbott Laboratories is slated to report first-quarter 2023 results on Apr. 19 before the market opens. 
Via Talk Markets
3 No-Brainer Medical Device Stocks to Buy Right Now
These companies have consistently delivered revenue and EPS gains. 
Via The Motley Fool
3 Discounted Dividend Stocks With Combined 150+ Years Of Dividend Growth
All three of these dividend stocks have paid a growing dividend for more than 25 years each 
Via The Motley Fool
10 Analysts Have This to Say About Abbott Laboratories
Via Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
Via Benzinga
2 Top Dividend Kings to Buy for the Long Haul
These aren't just dividend plays, either. 
Via The Motley Fool
Better Dividend Stock: AbbVie vs. Johnson & Johnson
Both companies have a lot to offer income-seekers. 
Via The Motley Fool
3 Dividend-Growth Stocks to Buy in April That Can Crush Inflation
No need to worry about keeping up with inflation with these rapidly growing payouts. 
Via The Motley Fool
3 Healthcare Stocks to Watch As the Industry Evolves
Healthcare stocks are often considered a safe investment due to the consistent demand for medical products and services. 
Via InvestorPlace
2 Dividend Stocks Down 11% to 22% to Buy and Hold Forever
Investors should buy the dips on these healthcare giants. 
Via The Motley Fool
Can Healthcare Stocks Survive Macro Headwinds?
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
2 High-Yield Dividend Stocks You Won't Regret Buying Right Now
These two blue-chip dividend stocks offer investors a reliable income stream in a volatile market. 
Via The Motley Fool
Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage
House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Healthcare Stocks With at Least 30 Years of Dividend Increases
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield. 
Via MarketBeat
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
Via Benzinga
2 Top Dividend Stocks You Can Buy and Hold Forever
These two companies have been growing their payouts for more than a century combined. 
Via The Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
Via Benzinga
Why The Apple Watch Comes Up Short In Heart Attack Detection… And Other Alternatives
While there can be some value in having a single-lead ECG always available, patients with known heart conditions need much better technology. 
Via Talk Markets
7 Dividend Kings to Buy for an Uncertain Market Environment
With so much turbulence in the global economy, these dividend kings to buy may help you weather the extreme storm. 
Via InvestorPlace
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading
Over the past week, the market had a nice uptick making it harder for defensive sectors like healthcare to get traction up only 0.51% and down almost 5% YTD. 
Via Talk Markets
Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories
The FDA will allow two of Abbott's CGMs to be paired with automated insulin pumps. 
Via Investor's Business Daily
Abbott's MitraClip Shows Long Term Benefits In Patients With Leaky Heart Valves
Via Benzinga
Data Shows Abbott's TriClip System Superior To Other Medical Therapy In Heart Valve Disorder
Via Benzinga
2 High-Yield Dividend Stocks to Buy in March
Putting some shares of these stocks in your portfolio now could lead to heaps of passive income in your retirement years. 
Via The Motley Fool
ABBOTT LABORATORIES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Abbott Laboratories - ABT
From Kahn Swick & Foti, LLC
Via Business Wire
1 High-Flying Growth Stock With 19% Upside, According to Wall Street
This company could keep going up, but beware of the risks. 
Via The Motley Fool
Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices
The decision came months ahead of Dexcom's and Abbott's expectations. 
Via Investor's Business Daily
Build Your Wealth by Buying and Holding These 2 Dividend Stocks for at Least 20 Years
The road to wealth is long, but it'll be a bit shorter with the right investments. 
Via The Motley Fool
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.